AlloVir Inc. (ALVR): Price and Financial Metrics

AlloVir Inc. (ALVR): $0.95

0.02 (+2.52%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add ALVR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#87 of 328

in industry

ALVR Price/Volume Stats

Current price $0.95 52-week high $2.49
Prev. close $0.93 52-week low $0.58
Day low $0.87 Volume 616,200
Day high $0.97 Avg. volume 613,366
50-day MA $0.79 Dividend yield N/A
200-day MA $0.76 Market Cap 109.99M

ALVR Stock Price Chart Interactive Chart >


AlloVir Inc. (ALVR) Company Bio


AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The firm's technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. The company was founded by Malcolm K. Brenner, Juan F. Vera, Helen E. Heslop, Cliona M. Rooney, John Wilson, and Ann M. Leen in 2013 and is headquartered in Houston, TX.


ALVR Latest News Stream


Event/Time News Detail
Loading, please wait...

ALVR Latest Social Stream


Loading social stream, please wait...

View Full ALVR Social Stream

ALVR Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!